Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017037232) ANIDULAFUNGIN FORMULATIONS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/037232 International Application No.: PCT/EP2016/070718
Publication Date: 09.03.2017 International Filing Date: 02.09.2016
IPC:
A61K 9/19 (2006.01) ,A61K 9/08 (2006.01) ,A61K 38/12 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
14
Particulate form, e.g. powders
19
lyophilised
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
08
Solutions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
04
Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
12
Cyclic peptides
Applicants:
XELLIA PHARMACEUTICALS APS [DK/DK]; Dalslandsgate 11 DK-2300 København, DK
Inventors:
JASPRICA, Ivona; HR
ALILOVIC, Katarina; HR
Agent:
ONSAGERS AS; P.O.BOX 1813, Vika N-0123 Oslo, NO
Priority Data:
62/213,54302.09.2015US
Title (EN) ANIDULAFUNGIN FORMULATIONS
(FR) FORMULATIONS D'ANIDULAFUNGINE
Abstract:
(EN) The present invention is directed to stable formulations comprising therapeutically effective amount of anidulafungin and buffering agent selected from glutamic, picolinic and benzoic acid.
(FR) La présente invention concerne des formulations stables comprenant une quantité thérapeutiquement efficace d'anidulafungine et un agent tampon choisi parmi l'acide glutamique, picolinique et benzoïque.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)